Unfortunately, hospitals in many low- and middle-income countries or regions such as western provinces of China, where professional tumor pathologic examination may be unavailable, and technical or financial resources may be also not enough to perform genomic analysis of ploidy, genetic aberrations of chromosomes and MYCN status. This evidence concerns the gene MYCN and neoplasm.